Medscape is available in 5 Language Editions – Choose your Edition here.


Intraocular Lens Dislocation Treatment & Management

  • Author: Lihteh Wu, MD; Chief Editor: Hampton Roy, Sr, MD  more...
Updated: Sep 29, 2015

Medical Care

Selection of treatment in the case of a decentered IOL should be based on the patient's symptoms, needs, and expectations.

Observation: In the absence of symptoms and no evidence of inflammatory sequelae, observation is an option. In the case of an ACIOL associated with a peaked or oval pupil, careful observation is warranted if there are no signs or symptoms of intraocular inflammation.

Miotics: If symptoms from a decentered PCIOL are infrequent and limited to evening, due to a dilated pupil, these patients may be treated conservatively by using a topical miotic such as pilocarpine 0.5-1% qhs. A trial of miotic agents may be warranted prior to removing or repositioning an implant.

Observation may be recommended in dislocated IOLs if the following conditions are met:

  • The IOL is not mobile.
  • There are no retinal complications.
  • The patient is satisfied with aphakic spectacle correction or contact lenses.

Surgical Care

When more severe and disabling symptoms or if inflammation is present with the potential for further complications in the future, treatment should include either repositioning, explanting, or exchanging the decentered IOL.[12] Selection of treatment is based on the patient's symptoms, visual needs, and expectations, and an assessment of which option is likely to provide the best long-term benefit with the least risk.

  • IOL reposition: An IOL may become decentered due to either insufficient zonular support or to irregular fibrosis of the posterior capsule. In the case of inadequate support, early in the postoperative period the surgeon may attempt to rotate the IOL surgically where there is clinical evidence of sufficient capsule and zonules to support the implant. A helpful maneuver is the bounce test where the optic is pushed gently toward each haptic to ensure spontaneous recentration.
  • IOL reposition with McCannel sutures: In some cases, repositioning may be supplemented by the use of trans-iris IOL fixation (McCannel) suture.
  • IOL explantation: Certain circumstances warrant removal of an IOL without secondary IOL implantation. This is determined on an individual basis and taking into account the patient's expectation.
  • IOL exchange: The most common indications for removal or exchange of a modern PCL are wrong IOL power and malposition. Deformation of the implant due to irregular capsular fibrosis may make simple rotation insufficient to properly center the IOL. The IOL may be exchanged for an ACIOL, a sulcus-fixated IOL with or without McCannel sutures,  a transsclerally sutured PCIOL, or a posterior iris-claw IOL. [13]
  • To determine whether the risk-to-benefit ratio favors IOL exchange over observation, the surgeon should consider the following:
    • Severity, duration, and chronology of the problem
    • Response to nonsurgical treatment
    • Natural history of a specific IOL
    • Likelihood that surgical removal would provide substantial relief or benefits
    • Ease of surgical removal and potential for aggravating or creating additional complications
    • Status of the other eye
    • Patient and family expectations and visual needs
    • Life expectancy and overall health of the patient

Several indications for surgical intervention exist for a dislocated IOL. If the patient is not satisfied or cannot tolerate aphakic spectacle correction or contact lenses or if there is concomitant retinal pathology, such as a retinal detachment, surgery must be considered.

Several surgical options are available. These options include removal, exchange, or repositioning of the IOL. A multitude of techniques has been described on how to grasp, suture, and place the IOL. Repositioning of the IOL into the ciliary sulcus or over capsular remnants with less than a total of 6 clock hours of inferior capsular support is not a stable situation, as many of those repositioned IOLs will end up dislocating again. Transscleral suturing or IOL exchange (removal of the dislocated IOL and placement of a flexible open loop ACIOL) is recommended in these cases.

  • In 1996, Kelman proposed a technique called posterior-assisted levitation, in which nuclear fragments or dislocated IOLs into the anterior vitreous are retrieved through a pars plana sclerotomy and the insertion of a cyclodialysis spatula, a needle, or a viscosurgical device. However, this maneuver can be complicated with retinal detachment or cystoid macular edema and should not be performed at all.
  • If transscleral suturing of the IOL is planned, modifications to the usual placement of the sclerotomies are made. Two triangular scleral flaps are made 180 degrees apart in the horizontal meridian. Then, two sclerotomies are made 1-1.5 mm posterior to the limbus under the flaps. The infusion cannula is sutured to the usual position. A complete vitrectomy is performed, paying close attention to removing all vitreous and capsular attachments to the IOL, making it freely mobile. The posterior hyaloid, if still attached, is peeled. This allows the IOL to gently fall over the posterior pole of the eye.
  • If the IOL does not have positioning holes, the edge of the IOL is elevated with a lighted vitreoretinal pick or hook. If positioning holes are present, the IOL may be engaged through them by the pick or hook. The IOL is elevated into the midvitreous cavity, and the optic is grasped with serrated jaw foreign body forceps or diamond-coated forceps. The haptics should not be grasped, or they will be bent.
  • Aspiration through the silicone soft tipped cannula also has been used in the retrieval and manipulation of the IOL, but this technique may result in inadvertent vitreoretinal traction.
  • Silicone plate lenses are difficult to manipulate, and, in certain cases, standard techniques will not suffice. The endocryoprobe has been used to engage the IOL, but diamond-coated forceps are much safer. It is recommended that the gas pressure be lowered to 525 psi to avoid freezing the entire shaft. Another problem is that transscleral suturing is not an option because cheese wiring through the silicone will occur.
  • Liquid perfluorocarbons, such as Perflubron, can be used to float the IOL to the pupillary plane.
  • Once the IOL is engaged and elevated, it is brought to the posterior chamber. One haptic may be brought in front of the iris. The other haptic may be positioned in the sulcus. Using a Sinskey hook either through a limbal stab incision or through the sclerotomy, the IOL is rotated into place. If more than a total of 6 clock hours of capsular support are present inferiorly, one may elect to reposition the IOL into the sulcus without suturing it.
  • If there is not enough capsular support, either transscleral sutures or iris sutures are necessary. Several techniques have been described.
    • If the IOL has positioning holes, the haptics are rotated until they are in the vertical meridian. Single armed 9-0 Prolene sutures are grasped with intraocular forceps and introduced through the sclerotomies. They are passed through the positioning holes from posterior to anterior. The sutures are tied to the sclerotomies under the scleral flaps.
    • With the intraocular snare, one of the haptics may be looped, and, at the same time, a 7-0 Prolene suture can be tied to it.
    • Another option is to temporarily externalize the haptics through the sclerotomies so that they can be tied with 10-0 Prolene sutures. This technique may cause peripheral retina breaks or bleeding. The IOL is repositioned into the sulcus, and the sutures are secured to the sclerotomy.
    • Needle-guided techniques also have been described where a 9-0 or 10-0 Prolene suture may be threaded retrograde up the bore of a five-eighths-inch 25-gauge needle. The end of the suture that is not threaded is retrieved through the hub of the needle. This results in a suture loop. The needle with the suture is inserted through the base of the scleral flap. As the IOL is being grasped by forceps, the haptic is manipulated into the loop; then, the suture is tied under the scleral flaps.
  • Under certain situations, an IOL must be exchanged. For instance, if the dislocated IOL is damaged (ie, broken haptic), it must be removed. The damaged IOL may be removed through the pars plana or through a limbal incision at the surgeon's discretion. Pars plana removal increases the risk of retinal detachment and severe choroidal bleeding.
    • The surgeon has the choice of suturing a posterior IOL or inserting an ACIOL. Modern flexible open loop ACIOLs do not appear to result in the complications seen with older types (ie, corneal decompensation, uveitis-glaucoma-hyphema syndrome).
    • Another option is to manipulate the dislocated IOL into the anterior chamber and leave it there. Potential drawbacks of this option are endothelial cell and trabecular meshwork damage. This technique works well with 3-piece polymethyl methacrylate (PMMA) IOLS but requires a peripheral iridectomy to prevent pupillary block.
  • Perfluorocarbon liquids are very useful if a retinal detachment is also present. The perfluorocarbon liquid bubble displaces the subretinal fluid through the retinal breaks reattaching the retina and, at the same time, serves as a cushion between the IOL and the retina. Thus, the retina is protected from potential damage from IOL impact during surgical manipulation. If a silicone plate lens is dislocated, special care with the use of perfluorocarbon liquids is necessary. It has been reported that these lenses often "skate or glide" on the bubble across the retina. In addition, perfluorocarbon liquids make the grasping of the IOL somewhat more difficult by making the IOL more slippery. If the retina is not detached, the use of perfluorocarbon liquids probably is not necessary.
  • On certain cases, an ACIOL is present in addition to the dislocated IOL. Surgical management of these cases is made more difficult by the presence of the ACIOL, especially if a concomitant retinal detachment is present. The vitreoretinal surgeon has several options.
    • The surgeon may opt to remove the ACIOL, reposition the dislocated IOL, or suture the dislocated IOL.
    • Another option is to leave the ACIOL and remove the dislocated IOL. The dislocated IOL may be removed via the pars plana or through a limbal incision. If pars plana removal is entertained, a 7-mm partial-thickness scleral groove is created 3 mm posterior and parallel to the superior limbus. This groove should be contiguous with one of the superior sclerotomies. 8-0 silk sutures should be preplaced through the lips of the scleral groove. Once the IOL is ready to be extracted, the microvitreoretinal (MVR) blade is used to extend the sclerotomy into the scleral groove to make it full thickness. After the IOL is removed, the preplaced sutures are tied. This area is inspected by indirect ophthalmoscopy. If needed, retinopexy is applied.
    • If extraction through a limbal incision is planned, the ACIOL must be removed first. Then, the dislocated IOL is brought to the anterior chamber and removed through the limbal wound. The ACIOL is reinserted. The limbal wound is closed with 10-0 nylon sutures. The sclerotomies are closed in the usual fashion.
  • Although dislocated foldable IOLs were traditionally treated with removal of the lens and exchange to a PMMA IOL, one report demonstrates the feasibility of using existing surgical techniques to reposition the dislocated foldable IOLs.
  • A sutureless technique has recently been described. [14] A 27-gauge needle is passed through the ciliary sulcus, allowing externalization of the IOL haptics. A lamellar scleral dissection is performed, and the haptics are then fixed into this scleral tunnel. Using this technique, the authors report minimal tilt and other complications.


A vitreoretinal specialist should be consulted whenever this complication occurs.

Contributor Information and Disclosures

Lihteh Wu, MD Asociados de Macula Vitreo y Retina de Costa Rica

Lihteh Wu, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Retina Specialists, Association for Research in Vision and Ophthalmology, Club Jules Gonin, Macula Society, Pan-American Association of Ophthalmology, Retina Society

Disclosure: Received income in an amount equal to or greater than $250 from: Bayer Health; Quantel Medical; Heidelberg Engineering.


Rafael Alberto García, MD 

Disclosure: Nothing to disclose.

Robert H Graham, MD Consultant, Department of Ophthalmology, Mayo Clinic, Scottsdale, Arizona

Robert H Graham, MD is a member of the following medical societies: American Academy of Ophthalmology, Arizona Ophthalmological Society, American Medical Association

Disclosure: Partner received salary from Medscape/WebMD for employment.

Specialty Editor Board

Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

Steve Charles, MD Director of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine

Steve Charles, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Retina Specialists, Macula Society, Retina Society, Club Jules Gonin

Disclosure: Received royalty and consulting fees for: Alcon Laboratories.

Chief Editor

Hampton Roy, Sr, MD Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy, Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

Additional Contributors

Brian A Phillpotts, MD, MD 

Brian A Phillpotts, MD, MD is a member of the following medical societies: American Academy of Ophthalmology, American Diabetes Association, American Medical Association, National Medical Association

Disclosure: Nothing to disclose.


Teodoro Evans, MD Consulting Surgeon, Vitreo-Retinal Section, Clinica de Ojos, Costa Rica

Disclosure: Nothing to disclose.

  1. Davis D, Brubaker J, Espandar L, Stringham J, Crandall A, Werner L. Late in-the-bag spontaneous intraocular lens dislocation: evaluation of 86 consecutive cases. Ophthalmology. 2009 Apr. 116(4):664-70. [Medline].

  2. Gross JG, Kokame GT, Weinberg DV. In-the-bag intraocular lens dislocation. Am J Ophthalmol. 2004 Apr. 137(4):630-5. [Medline].

  3. Gimbel HV, Condon GP, Kohnen T, Olson RJ, Halkiadakis I. Late in-the-bag intraocular lens dislocation: incidence, prevention, and management. J Cataract Refract Surg. 2005 Nov. 31(11):2193-204. [Medline].

  4. Krepste L, Kuzmiene L, Miliauskas A, Januleviciene I. Possible predisposing factors for late intraocular lens dislocation after routine cataract surgery. Medicina (Kaunas). 2013. 49(5):229-34. [Medline].

  5. Fernandez-Buenaga R, Alio JL, Perez-Ardoy AL, et al. Late in-the-bag intraocular lens dislocation requiring explantation: risk factors and outcomes. Eye (Lond). 2013 Jul. 27(7):795-801; quiz 802. [Medline]. [Full Text].

  6. Shingleton BJ, Yang Y, O'Donoghue MW. Management and outcomes of intraocular lens dislocation in patients with pseudoexfoliation. J Cataract Refract Surg. 2013 Jul. 39(7):984-93. [Medline].

  7. Pueringer SL, Hodge DO, Erie JC. Risk of late intraocular lens dislocation after cataract surgery, 1980-2009: a population-based study. Am J Ophthalmol. 2011 Oct. 152(4):618-23. [Medline].

  8. Tappin MJ, Larkin DF. Factors leading to lens implant decentration and exchange. Eye (Lond). 2000 Oct. 14 Pt 5:773-6. [Medline].

  9. Mamalis N, Brubaker J, Davis D, Espandar L, Werner L. Complications of foldable intraocular lenses requiring explantation or secondary intervention--2007 survey update. J Cataract Refract Surg. 2008 Sep. 34(9):1584-91. [Medline].

  10. Al-Halafi AM, Al-Harthi E, Al-Amro S, El-Asrar AA. Visual outcome and complications of pars plana vitrectomy for dislocated intraocular lenses. Saudi J Ophthalmol. 2011 Apr. 25 (2):187-92. [Medline].

  11. Rusu I, Chen Z, Zizva J, Myung JS, Wald KJ. Incidence of cystoid macular edema with iris-fixated posterior chamber intraocular lenses in patients presenting with lens dislocation. Int Ophthalmol. 2014 Oct. 34 (5):1153-8. [Medline].

  12. Jakobsson G, Zetterberg M, Sundelin K, Stenevi U. Surgical repositioning of intraocular lenses after late dislocation: Complications, effect on intraocular pressure, and visual outcomes. J Cataract Refract Surg. 2013 Dec. 39(12):1879-85. [Medline].

  13. Gonnermann J, Klamann MK, Maier AK, Rjasanow J, Joussen AM, Bertelmann E, et al. Visual outcome and complications after posterior iris-claw aphakic intraocular lens implantation. J Cataract Refract Surg. 2012 Dec. 38 (12):2139-43. [Medline].

  14. Yamane S, Inoue M, Arakawa A, Kadonosono K. Sutureless 27-gauge needle-guided intrascleral intraocular lens implantation with lamellar scleral dissection. Ophthalmology. 2014 Jan. 121 (1):61-6. [Medline].

  15. Bourke RD, Gray PJ, Rosen PH, Cooling RJ. Retinal detachment complicating scleral-sutured posterior chamber intraocular lens surgery. Eye. 1996. 10 (Pt 4):501-8. [Medline].

  16. Campo RV, Chung KD, Oyakawa RT. Pars plana vitrectomy in the management of dislocated posterior chamber lenses. Am J Ophthalmol. 1989 Nov 15. 108(5):529-34. [Medline].

  17. Chan CK. An improved technique for management of dislocated posterior chamber implants. Ophthalmology. 1992 Jan. 99(1):51-7. [Medline].

  18. Chan CK, Agarwal A, Agarwal S, Agarwal A. Management of dislocated intraocular implants. Ophthalmol Clin North Am. 2001 Dec. 14(4):681-93. [Medline].

  19. Duffey RJ, Holland EJ, Agapitos PJ, Lindstrom RL. Anatomic study of transsclerally sutured intraocular lens implantation. Am J Ophthalmol. 1989 Sep 15. 108(3):300-9. [Medline].

  20. Flynn HW Jr. Pars plana vitrectomy in the management of subluxed and posteriorly dislocated intraocular lenses. Graefes Arch Clin Exp Ophthalmol. 1987. 225(3):169-72. [Medline].

  21. Framme C, Hoerauf H, Roider J, Laqua H. Delayed intraocular lens dislocation after neodymium: YAG capsulotomy. J Cataract Refract Surg. 1998 Nov. 24(11):1541-3. [Medline].

  22. Gonzalez GA, Irvine AR. Posterior dislocation of plate haptic silicone lenses. Arch Ophthalmol. 1996 Jun. 114(6):775-6. [Medline].

  23. Hayashi K, Hirata A, Hayashi H. Possible predisposing factors for in-the-bag and out-of-the-bag intraocular lens dislocation and outcomes of intraocular lens exchange surgery. Ophthalmology. 2007 May. 114(5):969-75. [Medline].

  24. Heilskov T, Joondeph BC, Olsen KR, Blankenship GW. Late endophthalmitis after transscleral fixation of a posterior chamber intraocular lens. Arch Ophthalmol. 1989 Oct. 107(10):1427. [Medline].

  25. Joo CK, Shin JA, Kim JH. Capsular opening contraction after continuous curvilinear capsulorhexis and intraocular lens implantation. J Cataract Refract Surg. 1996 Jun. 22(5):585-90. [Medline].

  26. Kokame GT, Yamamoto I, Mandel H. Scleral fixation of dislocated posterior chamber intraocular lenses: Temporary haptic externalization through a clear corneal incision. J Cataract Refract Surg. 2004 May. 30(5):1049-56. [Medline].

  27. Lanzetta P, Menchini U, Virgili G, Crovato S, Rapizzi E. Scleral fixated intraocular lenses: an angiographic study. Retina. 1998. 18(6):515-20. [Medline].

  28. Lewis H, Sanchez G. The use of perfluorocarbon liquids in the repositioning of posteriorly dislocated intraocular lenses. Ophthalmology. 1993 Jul. 100(7):1055-9. [Medline].

  29. Lubniewski AJ, Holland EJ, Van Meter WS, Gussler D, Parelman J, Smith ME. Histologic study of eyes with transsclerally sutured posterior chamber intraocular lenses. Am J Ophthalmol. 1990 Sep 15. 110(3):237-43. [Medline].

  30. Maguire AM, Blumenkranz MS, Ward TG, Winkelman JZ. Scleral loop fixation for posteriorly dislocated intraocular lenses. Operative technique and long-term results. Arch Ophthalmol. 1991 Dec. 109(12):1754-8. [Medline].

  31. Malbran ES, Malbran E Jr, Negri I. Lens guide suture for transport and fixation in secondary IOL implantation after intracapsular extraction. Int Ophthalmol. 1986 May. 9(2-3):151-60. [Medline].

  32. Marques FF, Marques DM, Osher RH, Freitas LL. Longitudinal study of intraocular lens exchange. J Cataract Refract Surg. 2007 Feb. 33(2):254-7. [Medline].

  33. Mittra RA, Connor TB, Han DP, Koenig SB, Mieler WF, Pulido JS. Removal of dislocated intraocular lenses using pars plana vitrectomy with placement of an open-loop, flexible anterior chamber lens. Ophthalmology. 1998 Jun. 105(6):1011-4. [Medline].

  34. Por YM, Chee SP. Posterior-assisted levitation: outcomes in the retrieval of nuclear fragments and subluxated intraocular lenses. J Cataract Refract Surg. 2006 Dec. 32(12):2060-3. [Medline].

  35. Ruiz-Moreno JM. Repositioning dislocated posterior chamber intraocular lenses. Retina. 1998. 18(4):330-4. [Medline].

  36. Schecter RJ. Suture-wick endophthalmitis with sutured posterior chamber intraocular lens. J Cataract Refract Surg. 1990. 16:1755-56.

  37. Schneiderman TE, Johnson MW, Smiddy WE, Flynn HW Jr, Bennett SR, Cantrill HL. Surgical management of posteriorly dislocated silicone plate haptic intraocular lenses. Am J Ophthalmol. 1997 May. 123(5):629-35. [Medline].

  38. Smiddy WE. Management of dislocated foldable intraocular lenses. Retina. 2005 Jul-Aug. 25(5):576-80. [Medline].

  39. Smiddy WE. Modification of scleral suture fixation technique for dislocated posterior chamber intraocular lens implants. Arch Ophthalmol. 1998 Jul. 116(7):967. [Medline].

  40. Smiddy WE, Flynn HW Jr. Management of dislocated posterior chamber intraocular lenses. Ophthalmology. 1991 Jun. 98(6):889-94. [Medline].

  41. Smiddy WE, Flynn HW Jr. Needle-assisted scleral fixation suture technique for relocating posteriorly dislocated IOLs. Arch Ophthalmol. 1993 Feb. 111(2):161-2. [Medline].

  42. Smiddy WE, Ibanez GV, Alfonso E, Flynn HW Jr. Surgical management of dislocated intraocular lenses. J Cataract Refract Surg. 1995 Jan. 21(1):64-9. [Medline].

  43. Solomon K, Gussler JR, Gussler C, Van Meter WS. Incidence and management of complications of transsclerally sutured posterior chamber lenses. J Cataract Refract Surg. 1993 Jul. 19(4):488-93. [Medline].

  44. Steinmetz RL, Brooks HL, Newell CK. Management of posteriorly dislocated posterior chamber intraocular lenses by vitrectomy and pars plana removal. Retina. 2004 Aug. 24(4):556-9. [Medline].

  45. Tuft SJ, Talks SJ. Delayed dislocation of foldable plate-haptic silicone lenses after Nd:YAG laser anterior capsulotomy. Am J Ophthalmol. 1998 Oct. 126(4):586-8. [Medline].

  46. Williams DF, Del Piero EJ, Ferrone PJ, Jaffe GJ, McDonald HR, Peters MA. Management of complications in eyes containing two intraocular lenses. Ophthalmology. 1998 Nov. 105(11):2017-22. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.